U.S. federal trademark · Serial No. 78426656 · Reg. No. 3056516
Medical testing services that measure residual cancer cells in a patient's tissue, blood, bone marrow or fluid ex vivo prior to, or after subjection to selected drugs, chemicals and/or other agents
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.